Campomelic Dysplasia: Clinical Trials

1 trial for Campomelic Dysplasia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 terminated. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Terminated 1

Follow Campomelic Dysplasia: new trials by email Literature Review of Campomelic Dysplasia trials Research Report on Campomelic Dysplasia

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Exploratory Study of Danicamtiv in Patients With Primary Dilated Cardiomyopathy (DCM) Due to Genetic Variants or Other Causalities
danicamtiv - Primary Familial Dilated Cardiomyopathy
Phase 2TerminatedBristol-Myers Squibb412020-08-042025-05-21

Narrower conditions

Cardiomyopathy, Dilated (1)  ·  Distal Myopathies (1)  ·  Hereditary Sensory and Autonomic Neuropathies (1)  ·  familial dilated cardiomyopathy (1)

Broader conditions

Cardiomegaly (1)  ·  Cardiomyopathies (1)  ·  Cardiovascular Diseases (1)  ·  Congenital Abnormalities (1)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)  ·  Genetic Diseases, Inborn (1)  ·  Heart Diseases (1)  ·  Heredodegenerative Disorders, Nervous System (1)  ·  Laminopathies (1)  ·  Muscular Diseases (1)  ·  Muscular Disorders, Atrophic (1)  ·  Muscular Dystrophies (1)  ·  Musculoskeletal Abnormalities (1)  ·  Musculoskeletal Diseases (1)  ·  Nervous System Diseases (1)

Sponsors

Bristol-Myers Squibb (1)

Countries

Germany (1)  ·  Spain (1)  ·  United Kingdom (1)  ·  United States (1)

Results publications

PMID 41217321

NIH funding

2019 (1)